Erschienen in:
20.01.2023 | Breast Oncology
Optimizing Sentinel Node Biopsy After Neoadjuvant Therapy: Striving to Know What We Do Not Know
verfasst von:
Steven G. Woodward, MD, Oluwadamilola M. Fayanju, MD, MA, MPHS, FACS
Erschienen in:
Annals of Surgical Oncology
|
Ausgabe 4/2023
Einloggen, um Zugang zu erhalten
Excerpt
Assessment of axillary lymph nodes in breast cancer patients via axillary lymph node dissection (ALND) and sentinel lymph node biopsy (SLNB) has been an integral part of staging and treatment paradigms for many years.
1 Since the advent of SLNB in the 1990s, surgeons have attempted to de-escalate the amount of surgery in the axilla to prevent complications such as lymphedema and neuropathy.
1‐3 …